About Amplified Sciences
Amplified Sciences is a Healthcare company based in West Lafayette (United States) founded in 2016 by Vincent Jo Davisson. Amplified Sciences has raised $6.18 million across 10 funding rounds from investors including NIH, HHS and National Science Foundation. Its chief executive, as recorded, is Diana Caldwell. Amplified Sciences offers products and services including PanCystProâ„¢. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Gastrointestinal Cancer. Its legal entity is AMPLIFIED SCIENCES, LLC. Its competitors include BiomaRx Therapeutics, Ultrasonic Medical Mapping and PancraGEN.
Company details
Developer of in-vitro diagnostic assays for early detection of pancreatic cancer. The companys lead assay is a PanCystPro is developed by using ultra-sensitive molecular sensing technology. Also, it is providing molecular diagnostic tools for cardiovascular, and chronic kidney diseases.
- Headquarters West Lafayette, United States
- Founders Vincent Jo Davisson
- SectorsHealthcare
- Website amplifiedsciences.com
- Social LinkedIn X
- Legal Name Amplified Sciences, Llc
- Total Equity Funding$6.18M (USD)
in 10 rounds
- InvestorsNIH
& 14 more
Products & Services of Amplified Sciences
Amplified Sciences offers a comprehensive portfolio of products and services, including PanCystPro™.
Detects biomarkers in pancreatic cyst fluid for cancer risk assessment.
Funding Insights of Amplified Sciences
Amplified Sciences has successfully raised a total of $6.18M across 10 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.18M
- Total Rounds 10
- First Round $1.14M
(Apr 2020)
- Investors Count 15
All 10 funding rounds of Amplified Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | Seed | – | OCA Ventures | ||
| Aug 2025 | $550,000 | Seed | – | – | – |
| Apr 2024 | $275,000 | Grant | – | – | |
| Mar 2024 | $274,750 | Grant | – | – | |
| Feb 2024 | $108,000 | Seed | – | Flywheel Fund | – |
| Jun 2023 | $400,000 | Grant | – | – | |
| May 2023 | $454,885 | Grant | – | – | |
| Mar 2023 | $2.58M | Seed | – | – | |
| Aug 2021 | $1.8M | Seed | – | OCA Ventures, Purdue Foundry | |
| Apr 2020 | $1.14M | Seed | – | Elevate Ventures, Gravity Ventures | – |
15 investors in total: 15 institutional.
Investors in Amplified Sciences
Amplified Sciences has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| flywheelfund.vc | ||||
| iuventures.com | ||||
Seed and early-stage US venture capital investments are managed. | ocaventures.com | Chicago, United States | ||
Support for technology commercialization and startup development is provided. | purduefoundry.com | West Lafayette, United States | ||
Tech & Life-Sciences focused VC Firm investing in the US | goldenseeds.com | New York, United States | ||
Houston Angel Network is focused on supporting startups with funding. | houstonangelnetwork.org | Houston, United States | ||
| chemicalangels.com | ||||
Gravity Ventures is operated as a seed capital fund. | 2008 | gravityventures.com | Indianapolis, United States | |
Early-stage investments are made in diverse sectors by the firm. | elevateventures.com | Indianapolis, United States | ||
Early-stage businesses are funded by St. Louis Arch Angels. | 2005 | stlouisarchangels.com | St. Louis, United States |
Investor details for Amplified Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Amplified Sciences
2 people are tracked at Amplified Sciences (2 in leadership).
| Name | Role | Group |
|---|---|---|
Vincent Jo Davisson | Founder | Leadership |
Diana Caldwell | CEO & President | Leadership |
Complete people profiles for Amplified Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Amplified Sciences
3 dated milestones of Amplified Sciences across 10 years, from founding to its latest funding, stage changes and deals.
- Founded Amplified Sciences is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Seed,.
Competitors of Amplified Sciences
Amplified Sciences has 3 listed competitors in our database. They include BiomaRx Therapeutics, Ultrasonic Medical Mapping and PancraGEN.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biomarx.com | 2014 | Cambridge, United States | Diagnostic and therapeutic tools for pancreatic cancer are developed. | |||
| umedmap.com | 2019 | Bethesda, United States | Developer of a diagnostic system for detecting pancreatic cancer | |||
| pancragen.com | 2014 | Pittsburgh, United States | Functions as a pathological testing tool for clinical diagnostics and analysis. |
Detailed competitors of Amplified Sciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
3 companies that operate in the same segment as Amplified Sciences (Oncology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Amplified Sciences
Complete news archive for Amplified Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amplified Sciences
Amplified Sciences was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Amplified Sciences is headquartered in West Lafayette, United States. It is registered at West Lafayette, Indiana, United States.
Diana Caldwell is the CEO of Amplified Sciences, as recorded in our data.
Amplified Sciences is a funded company, having raised a total of $6.18M across 10 funding rounds to date. The company's 1st funding round was a Seed of $1.14M, raised on Apr 2020.
Developer of in-vitro diagnostic assays for early detection of pancreatic cancer. The companys lead assay is a PanCystPro is developed by using ultra-sensitive molecular sensing technology. Also, it is providing molecular diagnostic tools for cardiovascular, and chronic kidney diseases.
Amplified Sciences's top competitors include BiomaRx Therapeutics, Ultrasonic Medical Mapping and PancraGEN.
Amplified Sciences offers PanCystProâ„¢.
Amplified Sciences has 15 investors. Key investors include NIH, HHS, National Science Foundation, Flywheel Fund, and IU Ventures.
Amplified Sciences operates through Amplified Sciences, Llc.